FDA Gives Sanofi Nasacort OTC Approval

Source: pharmamanufacturing.com

Oct 15, 2013

The FDA has approved Nasacort Allergy 24HR nasal spray as an over-the-countertreatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.

Chattem, Sanofi's consumer healthcare division, anticipates that Nasacort will be available in Spring 2014.

This approval makes Nasacort the first and only medicine in its class to be available without a prescription and sets a regulatory precedent for other drugmakers looking to switch drugs from prescription to over the counter status.

Read the Sanofi press release here

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments